Article
SLCO1B1 genetic variation and hormone therapy in menopausal women.
Menopause (New York, N.Y.) - 1 Aug 2018
Moyer Ann M, de Andrade Mariza, Faubion Stephanie S, Kapoor Ekta, Dudenkov Tanda, Weinshilboum Richard M, Miller Virginia M
Abstract excerpt
OBJECTIVE: Response to menopausal hormone therapy (MHT) shows individual variation. SLCO1B1 encodes the OATP1B1 transporter expressed in the liver that transports many endogenous substances, including estrone sulfate, from the blood into hepatocytes. This study evaluated the relationship between genetic variation in SLCO1B1 and response to MHT in women enrolled in the Kronos Early Estrogen Prevention Study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
